Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mineralys Therapeutics, Inc. - Common Stock
(NQ:
MLYS
)
27.10
-0.25 (-0.91%)
Streaming Delayed Price
Updated: 1:15 PM EDT, Aug 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
234,187
Open
27.09
Bid (Size)
27.08 (100)
Ask (Size)
27.10 (100)
Prev. Close
27.35
Today's Range
27.07 - 28.09
52wk Range
12.59 - 47.65
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date
↗
July 16, 2026
This executive exercised 20,407 options at $1.08 and immediately sold them at $27.28 per share.
Via
The Motley Fool
Topics
Regulatory Compliance
What to Know About This Mineralys Insider Sale Before a December FDA Date
↗
July 16, 2026
Insider divested 2% of direct holdings via pre-planned Rule 10b5-1 trading arrangement, following a 90% stock surge over the past year.
Via
The Motley Fool
Topics
Regulatory Compliance
Performance
YTD
-24.1%
-24.1%
1 Month
-4.5%
-4.5%
3 Month
-8.8%
-8.8%
6 Month
-14.6%
-14.6%
1 Year
+105.5%
+105.5%
More News
Read More
What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision
↗
June 23, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Mineralys Therapeutics Inc (NASDAQ:MLYS) First Quarter 2026 Results Show Modest Market Reaction to FDA NDA Acceptance
↗
May 06, 2026
Via
Chartmill
Mineralys Therapeutics Inc (NASDAQ:MLYS) Reports Q4 2025 EPS Beat and Key FDA NDA Acceptance for Lorundrostat
↗
March 12, 2026
Via
Chartmill
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million
↗
May 31, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Mineralys (MLYS) Q1 2026 Earnings Transcript
↗
May 06, 2026
Via
The Motley Fool
Mineralys Therapeutics' CEO Sold Shares Worth $1.97 Million. Should Investors Avoid the Stock?
↗
April 07, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Cancer Drug Maker With $172 Million Revenue and Multiple Approved Therapies Draws $6.5 Million Investment
↗
March 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Biotech Stock Up 365% as This $8 Million Investment Targets a Drug With 3 NDA Filings Planned
↗
March 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Mineralys (MLYS) Q4 2025 Earnings Call Transcript
↗
March 12, 2026
Via
The Motley Fool
Topics
Earnings
Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears
↗
December 23, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys
↗
November 27, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
MINERALYS THERAPEUTICS INC (NASDAQ:MLYS) Beats Q3 2025 EPS Estimates and Advances Key Drug Candidate
↗
November 10, 2025
Via
Chartmill
Uncovering Potential: Mineralys Therapeutics's Earnings Preview
↗
November 07, 2025
Via
Benzinga
These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing?
↗
September 21, 2025
Via
The Motley Fool
It's a Small World: 3 Stocks Leading the Sudden Rebound in Small Caps
↗
September 16, 2025
Via
The Motley Fool
Topics
Economy
Stocks
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts
↗
September 07, 2025
Via
The Motley Fool
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
September 03, 2025
Via
Benzinga
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
↗
September 03, 2025
Via
Benzinga
Here are the top movers in Tuesday's session.
↗
September 02, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
September 02, 2025
Via
Benzinga
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.
↗
September 02, 2025
Via
Chartmill
Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
↗
September 02, 2025
Via
Benzinga
Frequently Asked Questions
Is Mineralys Therapeutics, Inc. - Common Stock publicly traded?
Yes, Mineralys Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Mineralys Therapeutics, Inc. - Common Stock trade on?
Mineralys Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mineralys Therapeutics, Inc. - Common Stock?
The ticker symbol for Mineralys Therapeutics, Inc. - Common Stock is MLYS on the Nasdaq Stock Market
What is the current price of Mineralys Therapeutics, Inc. - Common Stock?
The current price of Mineralys Therapeutics, Inc. - Common Stock is 27.10
When was Mineralys Therapeutics, Inc. - Common Stock last traded?
The last trade of Mineralys Therapeutics, Inc. - Common Stock was at 08/10/26 01:15 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
